Results 171 to 180 of about 12,023 (194)

Flow cytometry enables rapid evaluation of novel, new and niche antimicrobial agents. [PDF]

Front Microbiol
Salisbury E, Mulroney K, Kopczyk MK, Paton T, Carson CF, Ho WS, Chakera A.   +6 more
europepmc   +1 more source

Pharmacokinetics of Aztreonam-Avibactam After Single- and Multiple-Dose Administration: A Phase 1, Open-Label Study in Healthy Chinese Participants and Ethnic Comparison with Non-Chinese Participants. [PDF]

Clin Pharmacol Drug Dev
Wang J, He J, Wu J, Zhang J, Ma Y, Ren X, Wei H, Zhang C, Zhu H, Raber SR, Cong S.   +10 more
europepmc   +1 more source

Avibactam Pharmacokinetic/Pharmacodynamic Targets [PDF]

Antimicrobial Agents and Chemotherapy, 2018
Avibactam is a novel non--lactam -lactamase inhibitor that has been approved in the United States and Europe for use in combination with ceftazidime.
Wright W Nichols, Paul Newell, Ian A Critchley   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Meropenem-Vaborbactam versus Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections

Antimicrobial Agents and Chemotherapy, 2020
Danya Roshdy
exaly  

Aztreonam-avibactam may not replace ceftazidime/avibactam: the case of KPC-21 carbapenemase and penicillin-binding protein 3 with four extra amino acids

International Journal of Antimicrobial Agents, 2022
Zhiyong Zong, Yu Feng
exaly  

Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections

Antimicrobial Agents and Chemotherapy, 2017
Ryan K Shields, Liang Chen, Shaoji Cheng   +2 more
exaly  

Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China

Clinical Microbiology and Infection, 2020
Quan Shi, Xueqing Wu, Murat áková
exaly  

Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

Antimicrobial Agents and Chemotherapy, 2017
Ryan K Shields, M Hong Nguyen, Liang Chen   +2 more
exaly  

Randomized pharmacokinetic and drug–drug interaction studies of ceftazidime, avibactam, and metronidazole in healthy subjects

Pharmacology Research and Perspectives, 2015
Shampa Das, Jon Armstrong, Timi Edeki
exaly  

Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.

Clinical Infectious Diseases, 2016
Ryan K Shields, Brian A Potoski, Ghady Haidar   +2 more
exaly